CXCR4 and CCR5 ligands cooperate in monocyte and lymphocyte migration and in inhibition of dual-tropic (R5/X4) HIV-1 infection

European Journal of Immunology

Volumn 41, Issue 4, 2011, Pages 963-973

  Gouwy, Mieke ^a   Struyf, Sofie ^a   Berghmans, Nele ^a   Vanormelingen, Christophe ^a   Schols, Dominique ^a   Van Damme, Jo ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Chemotaxis; HIV 1; Lymphocytes; Monocytes; Synergy

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MARAVIROC; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 2; PLERIXAFOR; RANTES; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CD3+ T LYMPHOCYTE; CELL MIGRATION; CHEMOTAXIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LYMPHOBLAST; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VIRUS REPLICATION; VIRUS TRANSMISSION;

CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL12; HIV-1; HUMANS; LIGANDS; LYMPHOCYTE ACTIVATION; MAP KINASE SIGNALING SYSTEM; MONOCYTES; RECEPTORS, CCR5; RECEPTORS, CXCR4; T-LYMPHOCYTES;

EID: 79953042688     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041178     Document Type: Article

References (49)

1. Princen, K. and Schols, D., HIV chemokine receptor inhibitors as novel anti-HIV drugs. Cytokine Growth Factor Rev. 2005. 16: 659-677.
2. Sozzani, S., Zhou, D., Locati, M., Rieppi, M., Proost, P., Magazin, M., Vita, N. et al., Receptor and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3. J. Immunol. 1994. 152: 3615-3622.
3. Sica, A., Saccani, A., Borsatti, A., Power, C. A., Wells, T. N. C., Luini, W., Polentarutti, N. et al., Bacterial lipopolysaccharide rapidly inhibits expression of CC chemokine receptors in human monocytes. J. Exp. Med. 1997. 185: 969-974.
4. Johnson, Z., Proudfoot, A. E. and Handel, T. M., Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention. Cytokine Growth Factor Rev. 2005. 16: 625-636.
5. Locati, M., Torre, Y. M., Galliera, E., Bonecchi, R., Bodduliri, H., Vago, G., Vecchi, A. and Mantovani, A., Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines. Cytokine Growth Factor Rev. 2005. 16: 679-686.
6. Colditz, I. G., Schneider, M. A., Pruenster, M. and Rot, A., Chemokines at large: in-vivo mechanisms of their transport, presentation and clearance. Thromb. Haemost. 2007. 97: 688-693.
7. Mortier, A., Van Damme, J. and Proost, P., Regulation of chemokine activity by posttranslational modification. Pharmacol. Ther. 2008. 120: 197-217.
8. Gouwy, M., Struyf, S., Proost, P. and Van Damme, J., Synergy in cytokine and chemokine networks amplifies the inflammatory response. Cytokine Growth Factor Rev. 2005. 16: 561-580.
9. Venetz, D., Ponzoni, M., Schiraldi, M., Ferreri, A. J., Bertoni, F., Doglioni, C. and Uguccioni, M., Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells. Int. J. Cancer 2010. 127: 2300-2312.
10. Gouwy, M., Struyf, S., Noppen, S., Schutyser, E., Springael, J. Y., Parmentier, M., Proost, P., and Van Damme, J., Synergy between co-produced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events. Mol. Pharmacol. 2008. 74: 485-495.
11. Kuscher, K., Danelon, G., Paoletti, S., Stefano, L., Schiraldi, M., Petkovic, V., Locati, M. et al., Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes. Eur. J. Immunol. 2009. 39: 1118-1128.
12. Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H. et al., International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 2000. 52: 145-176.
13. Alkhatib, G., Combadière, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M. and Berger, E. A., CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996. 272: 1955-1958.
14. Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, J., Arenzana-Seisdedos, F., Schwartz, O. et al., The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line adapted HIV-1. Nature 1996. 382: 833-835.
15. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P. et al., Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996. 381: 661-666.
16. Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S. and Landau, N. R., Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 1997. 185: 621-628.
17. Glushakova, S., Yi, Y., Grivel, J. C., Singh, A., Schols, D., De Clercq, E., Collman, R. G. and Margolis, L., Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo. J. Clin. Invest. 1999. 104: R7-R11.
18. Taub, D. D., Conlon, K., Lloyd, A. R., Oppenheim, J. J. and Kelvin, D. J., Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1alpha and MIP-1 beta. Science 1993. 260: 355-358.
19. Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C. and Lusso, P., Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995. 270: 1811-1815.
20. Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J. and Springer, T. A., The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996. 382: 829-833.
21. Feng, Y., Broder, C. C., Kennedy, P. E. and Berger, E. A., HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996. 272: 872-877.
22. Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M. et al., A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996. 85: 1149-1158.
23. Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C. M., Saragosti, S. et al., Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996. 382: 722-725.
24. Menten, P., Struyf, S., Schutyser, E., Wuyts, A., De Clercq, E., Schols, D., Proost, P. and Van Damme, J., The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine. J. Clin. Invest. 1999. 104: R1-R5.
25. Gonzalez, E., Kulkarni, H., Bolivar, H., Mangano, A., Sanchez, R., Catano, G., Nibbs, R. J. et al., The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005. 307: 1434-1440.
26. Aquaro, S., Menten, P., Struyf, S., Proost, P., Van Damme, J., De Clercq, E. and Schols, D., The LD78â isoform of MIP-1á is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages. J. Virol. 2001. 75: 4402-4406.
27. Schols, D., Struyf, S., Van Damme, J., Esté, J. A., Henson, G. and De Clercq, E., Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J. Exp. Med. 1997. 186: 1383-1388.
28. Dorr, P., Westby, M., Dobbs, S., Griffin, P., Irvine, B., Macartney, M., Mori, J. et al., Maraviroc (UK-427, 857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob. Agents Chemother. 2005. 49: 4721-4732.
29. Tremblay, C. L., Kollmann, C., Giguel, F., Chou, T. C. and Hirsch, M. S., Strong in vitro synergy between the fusion inhibitor T-20 and the CXCR4 blocker AMD-3100. J. Acquir. Immune Defic. Syndr. 2000. 25: 99-102.
30. Vermeire, K., Princen, K., Hatse, S., De Clercq, E., Dey, K., Bell, T. W. and Schols, D., CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro. AIDS 2004. 18: 2115-2125.
31. Princen, K., Hatse, S., Vermeire, K., Aquaro, S., De Clercq, E., Gerlach, L., Rosenkilde, M. et al., Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist. J. Virol. 2004. 78: 12996-13006.
32. Struyf, S., De Meester, I., Scharpé, S., Lenaerts, J. P., Menten, P., Wang, J. M., Proost, P. and Van Damme, J., Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor. Eur. J. Immunol. 1998. 28: 1262-1271.
33. Sebastiani, S., Danclon, G., Gerber, B. and Uguccioni, M., CCL22-induced responses are powerfully enhanced by synergy inducing chemokines via CCR4: evidence for the involvement of first β-strand of chemokine. Eur. J. Immunol. 2005. 35: 746-756.
34. Bai, Z., Hayasaka, H., Kobayashi, M., Li, W., Guo, Z., Jang, M. H., Kondo, A. et al., CXC chemokine ligand 12 promotes CCR7-dependent naive T cell trafficking to lymph nodes and Peyer's patches. J. Immunol. 2009. 182: 1287-1295.
35. Koenen, R. R. and Weber, C., Therapeutic targeting of chemokine interactions in atherosclerosis. Nat. Rev. Drug Discov. 2010. 9: 141-153.
36. Krug, A., Uppaluri, R., Facchetti, F., Dorner, B. G., Sheehan, K. C., Schreiber, R. D., Cella, M. and Colonna, M., IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation. J. Immunol. 2002. 169: 6079-6083.
37. Vanbervliet, B., Bendriss-Vermare, N., Massacrier, C., Homey, B., de Bouteiller, O., Brière, F., Trinchieri, G. and Caux, C., The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J. Exp. Med. 2003. 198: 823-830.
38. 4 histamine receptor mediates optimal migration of mast cell precursors to CXCL12. J. Allergy Clin. Immunol. 2007. 120: 827-834.
39. Honczarenko, M., Le, Y., Glodek, A. M., Majka, M., Campbell, J. J., Ratajczak, M. Z. and Silberstein, L. E., CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor. Blood 2002. 100: 2321-2329.
40. Hecht, I., Cahalon, L., Hershkoviz, R., Lahat, A., Franitza, S. and Lider, O., Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signalling, adhesion and chemotaxis. Int. Immunol. 2003. 15: 29-38.
41. Kaul, M., Ma, Q., Medders, K. E., Desai, M. K. and Lipton, S. A., HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ. 2007. 14: 296-305.
42. Sohy, D., Yano, H., de Nadai, P., Urizar, E., Guillabert, A., Javitch, J. A., Parmentier, M. and Springael, J. Y., Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists. J. Biol. Chem. 2009. 284: 31270-31279.
43. Contento, R. L., Molon, B., Boularan, C., Pozzan, T., Manes, S., Marullo, S. and Viola, A., CXCR4-CCR5: a couple modulating T cell functions. Proc. Natl. Acad. Sci. USA 2008. 105: 10101-10106.
44. + cells. J. Immunol. 2009. 183: 7478-7488.
45. Schreiber, T. H., Shinder, V., Cain, D. W., Alon, R. and Sackstein, R., Shear flow-dependent integration of apical and subendothelial chemokines in T-cell transmigration: implications for locomotion and the multistep paradigm. Blood 2007. 109: 1381-1386.
46. Neel, N. F., Schutyser, E., Sai, J., Fan, G. H. and Richmond, A., Chemokine receptor internalization and intracellular trafficking. Cytokine Growth Factor Rev. 2005. 16: 637-658.
47. Struyf, S., Proost, P., Lenaerts, J. P., Stoops, G., Wuyts, A. and Van Damme, J., Identification of a blood-derived chemoattractant for neutrophils and lymphocytes as a novel CC chemokine, Regakine-1. Blood 2001. 97: 2197-2204.
48. Gouwy, M., Struyf, S., Verbeke, H., Put, W., Proost, P., Opdenakker, G. and Van Damme, J., CC chemokine ligand-2 synergizes with the nonchemokine G protein-coupled receptor ligand fMLP in monocyte chemotaxis, and it cooperates with the TLR ligand LPS via induction of CXCL8. J. Leukoc. Biol. 2009. 86: 671-680.
49. Pauwels, R., Andries, K., Desmyter, J., Schols, D., Kukla, M. J., Breslin, H. J., Raeymaeckers, A. et al., Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivates. Nature 1990. 343: 470-474.